Karen S. Lynch - Apr 1, 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
President and CEO, Director
Signature
/s/ Karen S. Lynch
Stock symbol
CVS
Transactions as of
Apr 1, 2024
Transactions value $
$13,635,152
Form type
4
Date filed
4/3/2024, 04:47 PM
Previous filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock (Restricted) Award $3.6M +45.2K $79.56 45.2K Apr 1, 2024 Direct F1
transaction CVS Common Stock Tax liability -$4.93M -62K -45.34% $79.56 74.7K Apr 1, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $15M +188K $79.56 188K Apr 1, 2024 Common Stock 188K $79.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 4/1/2025.
F2 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units.
F3 Option becomes exercisable in four equal annual installments, commencing 4/1/2025.